A Phase II study of combination chemotherapy with TS-1 and Trastuzumab for patients with HER2 positive advanced or recurrent gastric cancer.
Phase of Trial: Phase II
Latest Information Update: 30 Oct 2017
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary) ; Trastuzumab (Primary)
- Indications Gastric cancer
- Focus Therapeutic Use
- Acronyms STAR
- 27 Oct 2017 Status changed from recruiting to discontinued.
- 22 Jun 2012 New trial record